Skip to main content
×
Home
    • Aa
    • Aa

Dietary fat and physiological determinants of plasma chylomicron remnant homoeostasis in normolipidaemic subjects: insight into atherogenic risk

  • Deasy Irawati (a1) (a2) (a3), John C. L. Mamo (a1) (a2), Karin M. Slivkoff-Clark (a1), Mario J. Soares (a1) (a2) and Anthony P. James (a1) (a2)...
Abstract
Abstract

TAG depleted remnants of postprandial chylomicrons are a risk factor for atherosclerosis. Recent studies have demonstrated that in the fasted state, the majority of chylomicrons are small enough for transcytosis to arterial subendothelial space and accelerate atherogenesis. However, the size distribution of chylomicrons in the absorptive state is unclear. This study explored in normolipidaemic subjects the postprandial distribution of the chylomicron marker, apoB-48, in a TAG-rich lipoprotein plasma fraction (Svedberg flotation rate (Sf>400), in partially hydrolysed remnants (Sf 20–400) and in a TAG-deplete fraction (Sf<20), following ingestion of isoenergetic meals with either palm oil (PO), rice bran or coconut oil. Results from this study show that the majority of fasting chylomicrons are within the potentially pro-atherogenic Sf<20 fraction (70–75 %). Following the ingestion of test meals, chylomicronaemia was also principally distributed within the Sf<20 fraction. However, approximately 40 % of subjects demonstrated exaggerated postprandial lipaemia specifically in response to the SFA-rich PO meal, with a transient shift to more buoyant chylomicron fractions. The latter demonstrates that heterogeneity in the magnitude and duration of hyper-remnantaemia is dependent on both the nature of the meal fatty acids ingested and possible metabolic determinants that influence chylomicron metabolism. The study findings reiterate that fasting plasma TAG is a poor indicator of atherogenic chylomicron remnant homoeostasis and emphasises the merits of considering specifically, chylomicron remnant abundance and kinetics in the context of atherogenic risk. Few studies address the latter, despite the majority of life being spent in the postprandial and absorptive state.

Copyright
Corresponding author
* Corresponding author: Dr A. P. James, fax +61 8 9266 2958, email T.P.James@curtin.edu.au
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2. GM Dallinga-Thie , R Franssen , HL Mooij , et al. (2010) The metabolism of triglyceride-rich lipoproteins revisited: new players, new insight. Atherosclerosis 211, 18.

5. TG Redgrave (2004) Chylomicron metabolism. BiochemSoc Trans 32, 7982.

6. JCL Mamo , SD Proctor & D Smith (1998) Retention of chylomicron remnants by arterial tissue; importance of an efficient clearance mechanism from plasma. Atherosclerosis 141, Suppl. 1, S63S69.

7. A Alipour , P Valdivielso , JWF Elte , et al. (2010) ApoB48 as a marker of atherosclerosis in patients with familial lipid disorders, type 2 diabetes mellitus and coronary artery disease. Atheroscler Suppl 11, 6869.

8. N Sakai , Y Uchida , K Ohashi , et al. (2003) Measurement of fasting serum apoB-48 levels in normolipidemic and hyperlipidemic subjects by ELISA. J Lipid Res 44, 12561262.

9. F Karpe , G Steiner , K Uffelman , et al. (1994) Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis 106, 8397.

10. JW Su , MMU Nzekwu , MC Cabezas , et al. (2009) Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk. Eur J Clin Invest 39, 741754.

11. M Adiels , N Matikainen , J Westerbacka , et al. (2012) Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity. Atherosclerosis 222, 222228.

12. M Kinoshita , H Ohnishi , T Maeda , et al. (2009) Increased serum apolipoprotein B48 concentration in patients with metabolic syndrome. J Atheroscler Thromb 16, 517522.

13. CA Dane-Stewart , GF Watts , PHR Barrett , et al. (2003) Chylomicron remnant metabolism studied with a new breath test in postmenopausal women with and without type 2 diabetes mellitus. Clin Endocrinol (Oxf) 58, 415420.

14. CA Dane-Stewart , GF Watts , JCL Mamo , et al. (2001) Elevated apolipoprotein B-48 and remnant-like particle–cholesterol in heterozygous familial hypercholesterolaemia. Eur J Clin Invest 31, 113117.

15. F Karpe , ML Hellénius & A Hamsten (1999) Differences in postprandial concentrations of very-low-density lipoprotein and chylomicron remnants between normotriglyceridemic and hypertriglyceridemic men with and without coronary heart disease. Metabolism 48, 301307.

17. GM Dallinga-Thie , J Kroon , J Borén , et al. (2016) Triglyceride-rich lipoproteins and remnants: targets for therapy? Curr Cardiol Rep 18, 67.

18. SD Proctor & JCL Mamo (1998) Retention of fluorescent-labelled chylomicron remnants within the intima of the arterial wall: evidence that plaque cholesterol may be derived from post-prandial lipoproteins. Eur J Clin Invest 28, 497503.

20. SD Proctor , DF Vine & JCL Mamo (2004) Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 24, 21622167.

21. D Irawati , JCL Mamo , MJ Soares , et al. (2015) Hypertriglyceridemic subjects exhibit an accumulation of small dense chylomicron particles in the fasting state. Atherosclerosis 243, 236241.

22. H Campos , C Khoo & FM Sacks (2005) Diurnal and acute patterns of postprandial apolipoprotein B-48 in VLDL, IDL, and LDL from normolipidemic humans. Atherosclerosis 181, 345351.

23. CM Williams (1998) Dietary interventions affecting chylomicron and chylomicron remnant clearance. Atherosclerosis 141, Suppl. 1, S87S92.

24. CM Williams , PA Bateman , KG Jackson , et al. (2004) Dietary fatty acids and chylomicron synthesis and secretion. Biochem Soc Trans 32, 5558.

25. B Lamarche & P Couture (2015) Dietary fatty acids, dietary patterns, and lipoprotein metabolism. Curr Opin Lipidol 26, 4247.

27. D Esser , SJ van Dijk , E Oosterink , et al. (2013) A high-fat SFA, MUFA, or n-3 PUFA challenge affects the vascular response and initiates an activated state of cellular adherence in lean and obese middle-aged men. J Nutr 143, 843851.

28. B Ruiz-Núñez , DAJ Dijck-Brouwer & FAJ Muskiet (2016) The relation of saturated fatty acids with low-grade inflammation and cardiovascular disease. J Nutr Biochem 36, 120.

29. I Sato , Y Ishikawa , A Ishimoto , et al. (2009) Significance of measuring serum concentrations of remnant lipoproteins and apolipoprotein B-48 in fasting period. J Atheroscler Thromb 16, 1220.

30. RJ Havel , HA Eder & JH Bragdon (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest 34, 13451353.

31. AP James & JC Mamo (2012) Consumption of low doses of fat prevents the postprandial rise in chylomicron particle concentration and remnant accumulation in healthy normolipidaemic males. J Nutr Sci 1, 18.

32. E Bairaktari , K Hatzidimou , C Tzallas , et al. (2000) Estimation of LDL cholesterol based on the Friedewald formula and on apo B levels. Clin Biochem 33, 549555.

33. DR Matthews , JP Hosker & AS Rudenski (1985) Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412419.

34. M Kinoshita , M Kojima , T Matsushima , et al. (2005) Determination of apolipoprotein B-48 in serum by a sandwich ELISA. Clin Chim Acta 351, 115120.

36. M Miller , NJ Stone , C Ballantyne , et al. (2011) Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 22922333.

37. F Karpe , M Bell , J Bjorkegren , et al. (1995) Quantification of postprandial triglyceride-rich lipoproteins in healthy men by retinyl ester labeling and simultaneous measurement of apolipoproteins B-48 and B-100. Arterioscler Thromb Vasc Biol 15, 199207.

38. D Irawati , JCL Mamo , SS Dhaliwal , et al. (2016) Plasma triglyceride and high density lipoprotein cholesterol are poor surrogate markers of pro-atherogenic chylomicron remnant homeostasis in subjects with the metabolic syndrome. Lipids Health Dis 15, 19.

41. JR Mead , SA Irvine & DP Ramji (2002) Lipoprotein lipase: structure, function, regulation, and role in disease. J Mol Med 80, 753769.

42. JE Galgani , RD Uauy , CA Aguirre , et al. (2008) Effect of the dietary fat quality on insulin sensitivity. Br J Nutr 100, 471479.

43. G Riccardi , R Giacco & AA Rivellese (2004) Dietary fat, insulin sensitivity and the metabolic syndrome. Clin Nutr 23, 447456.

44. A Kennedy , K Martinez , CC Chuang , et al. (2009) Saturated fatty acid-mediated inflammation and insulin resistance in adipose tissue: mechanisms of action and implications. J Nutr 139, 14.

45. G Annuzzi , R Giacco , L Patti , et al. (2008) Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance. Nutr Metab Cardiovasc Dis 18, 531538.

46. M Maraki , N Aggelopoulou , N Christodoulou , et al. (2011) Validity of abbreviated oral fat tolerance tests for assessing postprandial lipemia. Clin Nutr 30, 852857.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

British Journal of Nutrition
  • ISSN: 0007-1145
  • EISSN: 1475-2662
  • URL: /core/journals/british-journal-of-nutrition
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Keywords:

Metrics

Full text views

Total number of HTML views: 67
Total number of PDF views: 688 *
Loading metrics...

Abstract views

Total abstract views: 1085 *
Loading metrics...

* Views captured on Cambridge Core between 20th February 2017 - 23rd September 2017. This data will be updated every 24 hours.